| |
 |
|
Class Information
Number: 424/153.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) > Binds eukaryotic cell or component thereof or substance produced by said eukaryotic cell > Hematopoietic cell
Description: Subject matter wherein the cell is a hematopoietic cell.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618633 |
Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses |
Nov. 17, 2009 |
| 7615219 |
Inhibition of PACAP signalling for the prevention and treatment of thrombocytopenia |
Nov. 10, 2009 |
| 7611707 |
Glycoprotein VI antibodies and methods thereof |
Nov. 3, 2009 |
| 7611708 |
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
Nov. 3, 2009 |
| 7604800 |
Anti-PSGL-1 antibodies |
Oct. 20, 2009 |
| 7592006 |
Composition comprising the LO-CD2a antibody |
Sep. 22, 2009 |
| 7592007 |
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
Sep. 22, 2009 |
| 7563441 |
Anti-P-selectin antibodies |
Jul. 21, 2009 |
| 7563442 |
Antibodies to CD40 and methods of treating cancer and enhancing immune responses |
Jul. 21, 2009 |
| 7563443 |
Monovalent anti-CD40L antibody polypeptides and compositions thereof |
Jul. 21, 2009 |
| 7563445 |
CD40 binding molecules and CTL peptides for treating tumors |
Jul. 21, 2009 |
| RE40811 |
Peripheralization of hematopoietic stem cells |
Jun. 30, 2009 |
| 7547438 |
CD40-binding activating antibodies |
Jun. 16, 2009 |
| 7537763 |
Anti-CD40 monoclonal antibody |
May. 26, 2009 |
| 7531175 |
Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules |
May. 12, 2009 |
| 7510713 |
Methods of inducing immunosuppression by administering 7C10 and 16C10 CD80-specific antibodies |
Mar. 31, 2009 |
| 7510712 |
Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antibodies |
Mar. 31, 2009 |
| 7510711 |
Methods for the treatment of cancer using anti-CD40 antibodies |
Mar. 31, 2009 |
| 7501124 |
Methods of inducing T-cell non-responsiveness with anti-gp39 24-31 antibodies |
Mar. 10, 2009 |
| 7501496 |
Anti-OX40L antibodies |
Mar. 10, 2009 |
| 7498032 |
Methods for treating immune disorders or cancer with anti-CD40 antibodies |
Mar. 3, 2009 |
| 7491393 |
Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodies |
Feb. 17, 2009 |
| 7482003 |
Treatment for asthma with .alpha.4-specific antibodies |
Jan. 27, 2009 |
| 7476385 |
Methods of inhibiting IgE responses to thymus-dependent antigens with the anti-gp39 antibody MR1 |
Jan. 13, 2009 |
| 7465464 |
Populations of cells that express flk-2 receptors |
Dec. 16, 2008 |
| 7462352 |
Methods of treatng B-cell diseases using humanized anti-CD19 antibodies |
Dec. 9, 2008 |
| 7445780 |
Antagonistic anti-CD40 antibodies |
Nov. 4, 2008 |
| 7445781 |
Anti-CD40CR MR1 antibody |
Nov. 4, 2008 |
| 7445798 |
Populations of cells that express FLK-1 receptors |
Nov. 4, 2008 |
| 7429647 |
Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use |
Sep. 30, 2008 |
| 7422744 |
Methods of treating cancer with alphavbeta3-specific antibodies |
Sep. 9, 2008 |
| 7422745 |
Methods of treating cancer with .sub.v.alpha..beta..sub.3-specific antibodies |
Sep. 9, 2008 |
| 7422739 |
Anti-CD20 antibodies |
Sep. 9, 2008 |
| 7399471 |
Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use |
Jul. 15, 2008 |
| 7393529 |
Methods and compositions for inhibiting binding of IgE to a high affinity receptor |
Jul. 1, 2008 |
| 7371382 |
Methods of inhibiting .alpha..sub.v.beta..sub.3-mediated binding with .alpha..sub.v.beta..sub.3-specific antibodies |
May. 13, 2008 |
| 7361344 |
Co-administration of a thrombolytic and an-anti-CD18 antibody in stroke |
Apr. 22, 2008 |
| 7354577 |
Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof |
Apr. 8, 2008 |
| 7338660 |
Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 |
Mar. 4, 2008 |
| 7323170 |
Anti-CD80 antibodies |
Jan. 29, 2008 |
| 7323171 |
Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction |
Jan. 29, 2008 |
| 7309489 |
Mouse CD40 ligand-specific antibodies and hybridomas |
Dec. 18, 2007 |
| 7288251 |
Antibodies to CD40 |
Oct. 30, 2007 |
| 7288252 |
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
Oct. 30, 2007 |
| 7259247 |
Anti-human T-cell costimulating polypeptide monoclonal antibodies |
Aug. 21, 2007 |
| 7192585 |
CD80 specific antibodies |
Mar. 20, 2007 |
| 7193064 |
Anti-CD40 monoclonal antibody |
Mar. 20, 2007 |
| 7175847 |
Treating intestinal inflammation with anti-CD80 antibodies that do not inhibit CD80 binding to CTLA-4 |
Feb. 13, 2007 |
| 7172759 |
Induction of cytotoxic T lymphocyte responses using anti-CD40 antibodies |
Feb. 6, 2007 |
| 7169389 |
Human CD154 binding molecules and treatment methods |
Jan. 30, 2007 |
|
|
|
